After a series of pilot animal studies on potential medical indications of its Closed Loop System (the CLS Neuromodulator), Victhom Human Bionics has filed a US provisional patent application entitled "Bio-Interfacing Closed Loop Platform for the Correction of Disorders and/or Deficiencies in a Physiological Process Such as Sleep Apnea," aimed at the management of respiratory disorders such as sleep apnea.

The patent application aims to protect the use of the CLS Neuromodulator that includes neurosensing and neurostimulating systems (NSS) directly interfacing with the peripheral nervous system (PNS). The CLS Neuromodulator may provide beneficial therapeutic effects to patients who suffer from respiratory disorders. The electrical stimulation signal is adjusted in accordance with the signals detected by the CLS Neuromodulator, which is designed to treat respiratory deficiencies.

More information can be found at http://www.victhom.com/index_en.htm.